rufinamide anticonvulsant medication used combination medication therapy treat various seizure disorders rufinamide triazole derivative developed novartis pharma ag manufactured eisai rufinamide approved us food drug administration fda november adjunctive treatment seizures associated lennoxgastaut syndrome children four years older adults official fdaapproved labeling mention use treatment partial seizures inasmuch clinical trials submitted fda marginal however several recent clinical trials suggest drug efficacy partial seizures marketed brand name also marketed european union brand name available generic mechanism action rufinamide fully understood evidence rufinamide modulate gating voltagegated sodium common target antiepileptic recent study indicates subtle effects voltagedependence gating time course inactivation sodium channel isoforms could reduce neuronal however action explain unique spectrum activity rufinamide httpsenwikipediaorgwikirufinamide